Looking foreward to speaking Thursday May 4th on the Alternative Careers in Chemistry Panel as part of the 31st Western Canadian Undergraduate Chemistry Conference (May 3 – 5, 2017 at the University of Alberta). This is being put on by Chemical Institute of Canada, American Chemical Society & University of Alberta.
You are browsing archives for
Month: April 2017
Notice to web log (blog) reader
Welcome! I hope you find some of the business and technology posts here to be of interest.
After April, 2017, blog posts reflect the time at which the information was originally posted, often simultaneously on Facebook, Twitter and LinkedIn. A major revision to the HJC Consulting website was pushed through in April, 2017, and reflects the creation of the blog; at that time, I ‘reposted’ several of HJC Consulting’s LinkedIn and Twitter posts with approximate dates from the last couple years here just for reference purposes.
Also, I’m happy to entertain requests to post articles on your microfluidic research or products; please send me an email if you’re interested.
Enjoy!
Interface Fluidics wins prize, unveils new website
Congratulations Interface Fluidics on your Accelerate Alberta 2017 prize! I love hearing microfluidics business success stories from anywhere, but it’s also great to see an Albertan and Canadian success. 🙂
Also, nice job on your new website!
Microfluidic female reproductive system emulator
Teresa Woodruff’s group of Northwestern University shows impressive multiplexed microfluidics mimic of the female reproductive system. Mimic is comprised of multiple connected microfluidics units and membrane pump & valves, and potentially allows for personalised drug efficacy & safety testing. See:
Microfluidics market projections by TMR
Cytofluidix article on recent Transparency Market Research Pvt. Ltd. report on microfluidics predicts nearly identical growth, 10.7% CAGR, as that from Future Market Insights last month. TMR report shows dominance by big hitters like Abbott, Danaher Corporation, Thermo Fisher Scientific and Roche.